Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Intravenous Fluid Transfer Drug Devices Market’s size between 2026 and 2030?

The market for intravenous fluid transfer drug devices has experienced substantial expansion in recent years. This market is projected to expand from $7.85 billion in 2025 to reach $8.35 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.3%. The historical growth can be linked to factors such as dependence on conventional IV sets, an increase in hospital and clinical procedures, the restricted supply of smart infusion devices, growing awareness regarding the benefits of IV therapy, and the adoption of PVC infusion bags.

The intravenous fluid transfer drug devices market size is projected to experience robust growth over the next few years. It is expected to expand to $10.55 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.0%. This anticipated growth can be attributed to several factors including technological advancements in smart infusion pumps, an increasing demand for pre-filled and multi-chamber infusion bags, expanding applications in oncology and neurology, the rise of home healthcare and ambulatory infusion, and more rigorous regulatory and quality standards. Significant trends during the forecast period involve the rising adoption of smart infusion devices and pumps, greater utilization of pre-filled and multi-chamber infusion bags, a growing need for needleless connectors and safety IV sets, the expansion of IV therapy across chronic and critical care treatments, and an enhanced focus on sterility, accuracy, and flow control.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp

Which Drivers Are Shaping Strategic Decisions In The Intravenous Fluid Transfer Drug Devices Market?

The increasing rate of hospitalizations is projected to drive the expansion of the intravenous fluid transfer drug device market in the future. This surge in hospitalization is fueled by factors such as an aging population, the prevalence of chronic illnesses, advancements in diagnostics, and improved healthcare access, in addition to lifestyle-related health issues and progress in medical technology. These fluid transfer systems facilitate the accurate and regulated delivery of both fluids and medications directly into the bloodstream for patients admitted to hospitals. For instance, in March 2023, GOV.UK, a US-based government agency, reported that in 2023, COVID-19 hospital admissions in England slightly increased to 10.62 per 100,000, while ICU/HDU admissions stayed low at 0.28 per 100,000. A majority of regions observed modest rises, and the rates largely remained consistent across various age demographics. Consequently, an escalating hospitalization rate is poised to stimulate the growth of the intravenous fluid transfer drug device market.

What Segment Classifications Make Up The Intravenous Fluid Transfer Drug Devices Market?

The intravenous fluid transfer drug devices market covered in this report is segmented –

1) By Type: Infusion Bags, Infusion Devices, Other Types

2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications

3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Subsegments:

1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags

2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices

3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices

How Are Emerging Trends Affecting The Progression Of The Intravenous Fluid Transfer Drug Devices Market?

Leading enterprises in the intravenous fluid transfer drug device market are developing modular and integrated infusion systems that include features like auto-identification to improve accuracy, boost patient safety, and streamline the dispensing of fluids and medications. Auto-identification in infusion systems automatically confirms and aligns medications with the correct patient through barcode scanning or RFID technology. For instance, in July 2023, Becton, Dickinson, and Company, a US-based medical device company, secured FDA 510(k) clearance for its enhanced BD Alaris Infusion System. The BD Alaris Infusion System incorporates updated hardware for its Point-of-Care Unit (PCU), comprising large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. It also introduces an advanced software version with bolstered cybersecurity and interoperability capabilities that permit smooth integration with widely used electronic medical record (EMR) systems, thereby supporting intelligent and connected healthcare.

Which Leading Companies Dominate The Intravenous Fluid Transfer Drug Devices Market Share?

Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Intravenous Fluid Transfer Drug Devices Market?

North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Intravenous Fluid Transfer Drug Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19535&type=smp

Browse Through More Reports Similar to the Global Intravenous Fluid Transfer Drug Devices Market 2026, By The Business Research Company

Neurovascular Catheters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurovascular-catheters-global-market-report

Peripheral Iv Catheters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Central Venous Catheters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/central-venous-catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company